These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9291715)

  • 1. Adverse effects of clomipramine.
    Brasić JR; Barnett JY; Sheitman BB; Tsaltas MO
    J Am Acad Child Adolesc Psychiatry; 1997 Sep; 36(9):1165-6. PubMed ID: 9291715
    [No Abstract]   [Full Text] [Related]  

  • 2. Clomipramine treatment for stereotype and related repetitive movement disorders associated with mental retardation.
    Lewis MH; Bodfish JW; Powell SB; Golden RN
    Am J Ment Retard; 1995 Nov; 100(3):299-312. PubMed ID: 8554777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clomipramine ameliorates adventitious movements and compulsions in prepubertal boys with autistic disorder and severe mental retardation.
    Brasic JR; Barnett JY; Kaplan D; Sheitman BB; Aisemberg P; Lafargue RT; Kowalik S; Clark A; Tsaltas MO; Young JG
    Neurology; 1994 Jul; 44(7):1309-12. PubMed ID: 8035936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of the toxic serotonin syndrome with chlorpromazine.
    Graham PM
    Med J Aust; 1997 Feb; 166(3):166-7. PubMed ID: 9059446
    [No Abstract]   [Full Text] [Related]  

  • 5. Augmenting selective serotonin reuptake inhibitors with clomipramine in obsessive-compulsive disorder: benefits and risks.
    Andrade C
    J Clin Psychiatry; 2013 Dec; 74(12):e1128-33. PubMed ID: 24434100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clomipramine in the treatment of compulsive behavior in frontotemporal dementia: a case series.
    Furlan JC; Henri-Bhargava A; Freedman M
    Alzheimer Dis Assoc Disord; 2014; 28(1):95-8. PubMed ID: 22892646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clomipramine as an alternative to selective serotonin reuptake inhibitors for patients at haemorrhagic risk.
    White R; Papadopoulos M; Tibrewal P
    Aust N Z J Psychiatry; 2022 Aug; 56(8):1045. PubMed ID: 35491848
    [No Abstract]   [Full Text] [Related]  

  • 8. A rare case of tardive dyskinesia and akathisia induced by citalopram.
    Birthi P; Walters C; Karandikar N
    PM R; 2010 Oct; 2(10):973-5. PubMed ID: 20970768
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotonergic antidepressant effects on aggressive, self-injurious and destructive/disruptive behaviours in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
    Janowsky DS; Shetty M; Barnhill J; Elamir B; Davis JM
    Int J Neuropsychopharmacol; 2005 Mar; 8(1):37-48. PubMed ID: 15482629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clomipramine discontinuation-emergent dystonia.
    Duggal HS; Dutta S; Sinha VK
    Aust N Z J Psychiatry; 2001 Oct; 35(5):696. PubMed ID: 11551294
    [No Abstract]   [Full Text] [Related]  

  • 11. [Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system].
    Baving L; Schmidt MH
    Z Kinder Jugendpsychiatr Psychother; 2000 Feb; 28(1):35-44. PubMed ID: 10746297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertraline and obsessive compulsive disorder: new indication. Limited assessment.
    Prescrire Int; 2000 Aug; 9(48):112-3. PubMed ID: 11067720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clomipramine treatment for self-injurious behavior of individuals with mental retardation: a double-blind comparison with placebo.
    Lewis MH; Bodfish JW; Powell SB; Parker DE; Golden RN
    Am J Ment Retard; 1996 May; 100(6):654-65. PubMed ID: 8735578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine treatment in a patient with Tourette's syndrome, obsessive-compulsive disorder and drug-induced mania.
    Matur Z; Uçok A
    Isr J Psychiatry Relat Sci; 2003; 40(2):150-2. PubMed ID: 14509206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin syndrome--clomipramine too soon after moclobemide?
    Gillman PK
    Int Clin Psychopharmacol; 1997 Nov; 12(6):339-42. PubMed ID: 9547136
    [No Abstract]   [Full Text] [Related]  

  • 16. Clomipramine and neuroleptic malignant syndrome: literature on adverse reactions to psychotropic drugs continues to confuse.
    Isbister GK; Buckley NA
    BMJ; 2005 Apr; 330(7494):790-1; author reply 791. PubMed ID: 15802729
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents.
    de Haan E; Hoogduin KA; Buitelaar JK; Keijsers GP
    J Am Acad Child Adolesc Psychiatry; 1998 Oct; 37(10):1022-9. PubMed ID: 9785713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for Treatment-Resistant Obsessive-Compulsive Disorder.
    Kayser RR
    J Clin Psychiatry; 2020 Sep; 81(5):. PubMed ID: 32926602
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonin syndrome induced by a combination of venlafaxine and clomipramine. A case report.
    Pinel-Ríos FJ; Peñuelas-Calvo I; Cerezo-Ramírez N; Hamad-Cueto O; García-Casares N
    Actas Esp Psiquiatr; 2016 Sep; 44(5):193-202. PubMed ID: 27644101
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonin syndrome as a result of clomipramine monotherapy.
    Rosebush PI; Margetts P; Mazurek MF
    J Clin Psychopharmacol; 1999 Jun; 19(3):285-7. PubMed ID: 10350043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.